זולאייר   150 מג ישראל - עברית - Ministry of Health

זולאייר 150 מג

novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.

היסטזין ישראל - עברית - Ministry of Health

היסטזין

trima israel pharmaceutical products maabarot ltd - cetirizine dihydrochloride - טבליה - cetirizine dihydrochloride 10 mg - cetirizine - cetirizine - antihistaminic drug for the treatment of allergies. for the treatment of seasonal and perennial allergic rhinitis and chronic idiopathic urticaria in children aged 6 years and over and adults.

דסלורטדין - תרימה טבליות ישראל - עברית - Ministry of Health

דסלורטדין - תרימה טבליות

trima israel pharmaceutical products maabarot ltd - desloratadine - טבליה - desloratadine 5 mg - desloratadine - desloratadine - for the relief of symptoms associated with allergic rhinitis, urticaria

אלרג'י X ישראל - עברית - Ministry of Health

אלרג'י x

teva israel ltd - loratadine - טבליה - loratadine 10 mg - other antihistamines for systemic use - relief of symptoms of allergy in seasonal allergic rhinitis, perennial allergic rhihitis, chronic urticaria.

Dental Surgical Stent – SurgiGuide™ ישראל - עברית - Ministry of Health

dental surgical stent – surgiguide™

ה.א.פרו בע"מ - רופא שיניים - מדריך כירורגי דנטאלי עבור שתלים

פניסטיל ג'ל ישראל - עברית - Ministry of Health

פניסטיל ג'ל

gsk consumer healthcare, israel ltd - dimetindene maleate - ג'ל - dimetindene maleate 0.1 %w/w - dimetindene - dimetindene - urticaria, pruritis, dermatoses, burns, insect bites, allergic dermatitis and eczema.

אילאריס 150 מגמל ישראל - עברית - Ministry of Health

אילאריס 150 מגמל

novartis israel ltd - canakinumab - אבקה להכנת תמיסה לזריקה - canakinumab 150 mg / 1 ml - canakinumab - canakinumab - cryopyrin - associated periodic syndromes (caps) in adults, adolescents and children aged 2 years and older with body weight above 7.5 kg, including : - mucle - wells syndrome (mws), - neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca), - severe forms of familial cold autoinflammatory syndrome (fcas) / familial cold urticaria (fcu) presenting with signs and symptoms beyond cold-induced urticarial skin rash.gouty arthritis:ilaris is indicated for the symptomatic treatment of adults patients with frequent gouty arthritis attacks (at least 3 attacks in the previous 12 months) in whom non-steroidal anti-inflammatory drugs (nsaids) and colchicine are contraindicated, are not tolerated, or do not provide an adequate response, and in whom repeated courses of corticosteroids are not appropriate.